Anthropic acquires biotech AI startup Coefficient Bio for $400M.

3/5

months

biotech startups, VCs, corporate strategy, AI ethicists

◆ What Changed

Anthropic focused on general AI → Expands into specific biotech applications.

◇ Why It Matters

Major LLM players are strategically investing in vertical AI markets.

🛠 Builder Opportunity

Build AI solutions for drug discovery, genomics, or medical research.

⚡ Next Step

→ Monitor LLM providers' vertical strategies for partnership opportunities.

📎 Sources